Senseonics Holdings
SENS on Nasdaq. Senseonics Holdings sells implantable glucose monitors to people with diabetes. Market value $580m.
Price checks use the past 12 months to September 2026. Quality checks use five annual reports, the latest for the year to December 2025.
Should I look at this?
Not a fit for our list right now
Why it could be worth it
See Industrials stocks that passed both tests
This is not advice. Check the numbers below.
For every $100 of what the whole company costs, it produced $-25.95 of spare cash in the past 12 months. A savings account pays about $4.
The filings do not give us enough to work this out.
Each dollar kept in the business earns -301 cents a year. Above 10 is good.
Quality score: 40 of 100. Price score: 0 of 100. Our list needs 70 on quality and 60 on price.
$8.02 a share, 67% above its 1-year low
Over the past year the price has ranged from $4.79 to $13.98.
Pays no dividend
Prices from Friday’s close (20 November).
Five years of cash, in billions
Spare cash swings from quarter to quarter here: a shortfall of $114 million in the past 12 months, a shortfall of $60 million in the year to December 2025.
| Revenue | |||||
| Revenue | $14m | $16m | $22m | $22m | $35m |
| Operating margin | |||||
| Operating margin | -418.1% | -418.7% | -337.7% | -333.0% | -193.8% |
| Debt to equity | |||||
| Debt to equity | n/a | n/a | 1.15 | n/a | 0.58 |
| Shares outstanding | |||||
| Shares outstanding | 0.48bn | 0.53bn | 0.59bn | 0.04bn | 0.05bn |
Health checks
- Free cash flow positive0 of 5 years
- Accounting checksSkipped: company is not yet profitable
- Debt0.58× equity
- Revenue growth, five yearsStrong, 48.1% a year
- Buying back its own sharesYes, 89% fewer since 2021
The quarter to September 2026
How the business did, compared with the same quarter a year earlier.
- Sales: $20 million last quarter, up 142% on a year ago.
- A loss of $33 million, compared with a loss of $20 million a year ago.
- It loses 201 cents on each $1 of sales, compared with 211 cents a year earlier.
- Over the past 12 months it spent $114 million more cash than it brought in, compared with $56 million a year earlier.
- 46% more shares than a year ago. Each share owns a bit less of the company.
- Debt is $6 million more than cash, up from $808,000 a year ago.
- Sales grew on a year ago in each of the last 4 quarters.
| Quarter to | Amount |
|---|---|
| December 2024 | $8m |
| March 2025 | $6m |
| June 2025 | $7m |
| September 2025 | $8m |
| December 2025 | $14m |
| March 2026 | $12m |
| June 2026 | $14m |
| September 2026 | $20m |
| Quarter to | Amount |
|---|---|
| December 2024 | -$15m |
| March 2025 | -$14m |
| June 2025 | -$15m |
| September 2025 | -$20m |
| December 2025 | -$21m |
| March 2026 | -$32m |
| June 2026 | -$37m |
| September 2026 | -$33m |
From the company's quarterly reports to the SEC.
Dates
- Next results (estimated)
- n/a
- Last annual report (10-K)
- 2 March 2026
- Next quarterly (estimated, 10-Q)
- 8 February 2027
Who owns it
None of the long-term investors we follow own it. 111 funds in all.
Largest holders overall
- Sessa Capital IM, L.P.$25mAdded
- BlackRock$16mAdded
- Vanguard Capital Management$10mAdded
- Avidity Partners Management LP$9mNew
- Sio Capital Management$9mAdded
- UBS Group AG$8mAdded
- Geode Capital Management$6mAdded
- Masters Capital Management$4mAdded
- State Street$3mAdded
- Marshall Wace, LLP$2mCut
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
3 investors own more than 5%.
- Sessa Capital IM, L.P.Passive investorat least 9.9%(filed with 1 related holder)Since 30 June 2026
- ROBERT J. SMITHPassive investorat least 6.1%(filed with 2 related holders)Since 19 May 2025
- BlackRock, Inc.Passive investor5.2%−1.4 ptsSince 30 September 2026
| Holder | Stake | Since | |
|---|---|---|---|
Sessa Capital IM, L.P. Passive investor | at least 9.9% (filed with 1 related holder) | 30 June 2026 | |
ROBERT J. SMITH Passive investor | at least 6.1% (filed with 2 related holders) | 19 May 2025 | |
BlackRock, Inc. Passive investor | 5.2%−1.4 pts | 30 September 2026 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
In the last 12 months, 2 insiders bought $627,303 of shares on the open market.
- ROEDER DOUGLAS ADirectorBought
- Date
- 13 November 2026
- Shares
- 17,041
- Price
- $10.32
- Value
- $175,860
- ROEDER DOUGLAS ADirectorBought
- Date
- 19 August 2026
- Shares
- 13,953
- Price
- $8.98
- Value
- $125,300
- ROEDER DOUGLAS ADirectorBought
- Date
- 12 May 2026
- Shares
- 22,686
- Price
- $5.56
- Value
- $126,134
- Goodnow Timothy TPresident and CEO, DirectorBought
- Date
- 13 March 2026
- Shares
- 17,225
- Price
- $5.79
- Value
- $99,733
- ROEDER DOUGLAS ADirectorBought
- Date
- 13 March 2026
- Shares
- 17,500
- Price
- $5.73
- Value
- $100,275
| Date | Who | Did | Shares | Price | Value |
|---|---|---|---|---|---|
| 13 November 2026 | ROEDER DOUGLAS A Director | Bought | 17,041 | $10.32 | $175,860 |
| 19 August 2026 | ROEDER DOUGLAS A Director | Bought | 13,953 | $8.98 | $125,300 |
| 12 May 2026 | ROEDER DOUGLAS A Director | Bought | 22,686 | $5.56 | $126,134 |
| 13 March 2026 | Goodnow Timothy T President and CEO, Director | Bought | 17,225 | $5.79 | $99,733 |
| 13 March 2026 | ROEDER DOUGLAS A Director | Bought | 17,500 | $5.73 | $100,275 |
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
None of the serious warning signs we check for were found. 1 thing worth knowing.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 2 Mar 2026, plus the 10-Q filed 9 Nov 2026 and 8 later 8-Ks.
One big customer
Worth knowingOne customer brings in a big share of sales: 53% last year. Losing that customer would hurt.
“For the year ended December 31, 2025 and 2024, sales to Ascensia accounted for 53% and 82% of total revenue, respectively.”
From the 10-K filed 2 March 2026, Item 8. Financial Statements and Notes. Read it in the filing
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
What could go wrong
Cheap for a reason is the question the numbers cannot answer.
Whether the price already reflects the risks is what the deep dive is for.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.